May 30, 2018
The Ministry of Health, Labor and Welfare (MHLW) added Japan’s first biosimilars for the anti-rheumatoid arthritis (RA) drug Enbrel (etanercept) and the anticancer drug Herceptin (trastuzumab) to the NHI drug price list on May 30. Mochida Pharmaceutical obtained approval for...read more